Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s ...

“To our knowledge, this is one of the largest clinical genomic correlative series of patients with prostate cancer liver metastases,” said Hayley N. Roberts, MBBS, MPH, of Vancouver Prostate ...

The study advanced beyond a one-size-fits-all model by developing both a global XGBoost classifier and cancer-type-specific ...

According to Source BioScience, the acquisition is set to “complement” its genomics and multiomics capabilities, broadening ...

Explore the transformative field of genomics with the power to solve humanity's greatest challenges and shape the future.

ONA-255 is a first-in-class molecule aimed at a new ADC target found in numerous common solid tumours. The collaboration is centred around Reveal Genomics’ chief scientific offi ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform ...

Aurora-based Children’s Hospital Colorado has opened an in-house genomics testing lab through its Precision Medicine Institute.  The lab enables genomic testing results to be more quickly integrated ...

Fortis Healthcare recently launched 'Fortis Institute of Genomic Medicines', a pioneering centre dedicated to harnessing the ...

Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL), a ...